5247422024-04-012024-09-305247422024-09-305247422024-04-012024-09-30RelatedPartyTransactionDomain15247422024-03-31RelatedPartyTransactionDomain15247422024-09-30RelatedPartyTransactionDomain15247422024-04-012024-09-30RelatedPartyTransactionDomain25247422024-03-31RelatedPartyTransactionDomain25247422024-09-30RelatedPartyTransactionDomain25247422024-04-012024-09-30RelatedPartyTransactionDomain35247422024-03-31RelatedPartyTransactionDomain35247422024-09-30RelatedPartyTransactionDomain35247422024-04-012024-09-30RelatedPartyTransactionDomain45247422024-03-31RelatedPartyTransactionDomain45247422024-09-30RelatedPartyTransactionDomain45247422024-04-012024-09-30RelatedPartyTransactionDomain55247422024-03-31RelatedPartyTransactionDomain55247422024-09-30RelatedPartyTransactionDomain55247422024-04-012024-09-30RelatedPartyTransactionDomain65247422024-03-31RelatedPartyTransactionDomain65247422024-09-30RelatedPartyTransactionDomain65247422024-04-012024-09-30RelatedPartyTransactionDomain75247422024-03-31RelatedPartyTransactionDomain75247422024-09-30RelatedPartyTransactionDomain75247422024-04-012024-09-30RelatedPartyTransactionDomain85247422024-03-31RelatedPartyTransactionDomain85247422024-09-30RelatedPartyTransactionDomain85247422024-04-012024-09-30RelatedPartyTransactionDomain95247422024-03-31RelatedPartyTransactionDomain95247422024-09-30RelatedPartyTransactionDomain95247422024-04-012024-09-30RelatedPartyTransactionDomain105247422024-03-31RelatedPartyTransactionDomain105247422024-09-30RelatedPartyTransactionDomain105247422024-04-012024-09-30RelatedPartyTransactionDomain115247422024-03-31RelatedPartyTransactionDomain115247422024-09-30RelatedPartyTransactionDomain115247422024-04-012024-09-30RelatedPartyTransactionDomain125247422024-03-31RelatedPartyTransactionDomain125247422024-09-30RelatedPartyTransactionDomain125247422024-04-012024-09-30RelatedPartyTransactionDomain135247422024-03-31RelatedPartyTransactionDomain135247422024-09-30RelatedPartyTransactionDomain135247422024-04-012024-09-30RelatedPartyTransactionDomain145247422024-03-31RelatedPartyTransactionDomain145247422024-09-30RelatedPartyTransactionDomain145247422024-04-012024-09-30RelatedPartyTransactionDomain155247422024-03-31RelatedPartyTransactionDomain155247422024-09-30RelatedPartyTransactionDomain155247422024-04-012024-09-30RelatedPartyTransactionDomain165247422024-03-31RelatedPartyTransactionDomain165247422024-09-30RelatedPartyTransactionDomain165247422024-04-012024-09-30RelatedPartyTransactionDomain175247422024-03-31RelatedPartyTransactionDomain175247422024-09-30RelatedPartyTransactionDomain175247422024-04-012024-09-30RelatedPartyTransactionDomain185247422024-03-31RelatedPartyTransactionDomain185247422024-09-30RelatedPartyTransactionDomain185247422024-04-012024-09-30RelatedPartyTransactionDomain195247422024-03-31RelatedPartyTransactionDomain195247422024-09-30RelatedPartyTransactionDomain195247422024-04-012024-09-30RelatedPartyTransactionDomain205247422024-03-31RelatedPartyTransactionDomain205247422024-09-30RelatedPartyTransactionDomain205247422024-04-012024-09-30RelatedPartyTransactionDomain215247422024-03-31RelatedPartyTransactionDomain215247422024-09-30RelatedPartyTransactionDomain215247422024-04-012024-09-30RelatedPartyTransactionDomain225247422024-03-31RelatedPartyTransactionDomain225247422024-09-30RelatedPartyTransactionDomain225247422024-04-012024-09-30RelatedPartyTransactionDomain235247422024-03-31RelatedPartyTransactionDomain235247422024-09-30RelatedPartyTransactionDomain235247422024-04-012024-09-30RelatedPartyTransactionDomain245247422024-03-31RelatedPartyTransactionDomain245247422024-09-30RelatedPartyTransactionDomain245247422024-04-012024-09-30RelatedPartyTransactionDomain255247422024-03-31RelatedPartyTransactionDomain255247422024-09-30RelatedPartyTransactionDomain255247422024-04-012024-09-30RelatedPartyTransactionDomain265247422024-03-31RelatedPartyTransactionDomain265247422024-09-30RelatedPartyTransactionDomain265247422024-04-012024-09-30RelatedPartyTransactionDomain275247422024-03-31RelatedPartyTransactionDomain275247422024-09-30RelatedPartyTransactionDomain275247422024-04-012024-09-30RelatedPartyTransactionDomain285247422024-03-31RelatedPartyTransactionDomain285247422024-09-30RelatedPartyTransactionDomain285247422024-04-012024-09-30RelatedPartyTransactionDomain295247422024-03-31RelatedPartyTransactionDomain295247422024-09-30RelatedPartyTransactionDomain295247422024-04-012024-09-30RelatedPartyTransactionDomain305247422024-03-31RelatedPartyTransactionDomain305247422024-09-30RelatedPartyTransactionDomain305247422024-04-012024-09-30RelatedPartyTransactionDomain315247422024-03-31RelatedPartyTransactionDomain315247422024-09-30RelatedPartyTransactionDomain315247422024-04-012024-09-30RelatedPartyTransactionDomain325247422024-03-31RelatedPartyTransactionDomain325247422024-09-30RelatedPartyTransactionDomain325247422024-04-012024-09-30RelatedPartyTransactionDomain335247422024-03-31RelatedPartyTransactionDomain335247422024-09-30RelatedPartyTransactionDomain335247422024-04-012024-09-30RelatedPartyTransactionDomain345247422024-03-31RelatedPartyTransactionDomain345247422024-09-30RelatedPartyTransactionDomain345247422024-04-012024-09-30RelatedPartyTransactionDomain355247422024-03-31RelatedPartyTransactionDomain355247422024-09-30RelatedPartyTransactionDomain355247422024-04-012024-09-30RelatedPartyTransactionDomain365247422024-03-31RelatedPartyTransactionDomain365247422024-09-30RelatedPartyTransactionDomain365247422024-04-012024-09-30RelatedPartyTransactionDomain375247422024-03-31RelatedPartyTransactionDomain375247422024-09-30RelatedPartyTransactionDomain375247422024-04-012024-09-30RelatedPartyTransactionDomain385247422024-03-31RelatedPartyTransactionDomain385247422024-09-30RelatedPartyTransactionDomain385247422024-04-012024-09-30RelatedPartyTransactionDomain395247422024-03-31RelatedPartyTransactionDomain395247422024-09-30RelatedPartyTransactionDomain395247422024-04-012024-09-30RelatedPartyTransactionDomain405247422024-03-31RelatedPartyTransactionDomain405247422024-09-30RelatedPartyTransactionDomain405247422024-04-012024-09-30RelatedPartyTransactionDomain415247422024-03-31RelatedPartyTransactionDomain415247422024-09-30RelatedPartyTransactionDomain415247422024-04-012024-09-30RelatedPartyTransactionDomain425247422024-03-31RelatedPartyTransactionDomain425247422024-09-30RelatedPartyTransactionDomain425247422024-04-012024-09-30RelatedPartyTransactionDomain435247422024-03-31RelatedPartyTransactionDomain435247422024-09-30RelatedPartyTransactionDomain435247422024-04-012024-09-30RelatedPartyTransactionDomain445247422024-03-31RelatedPartyTransactionDomain445247422024-09-30RelatedPartyTransactionDomain445247422024-04-012024-09-30RelatedPartyTransactionDomain455247422024-03-31RelatedPartyTransactionDomain455247422024-09-30RelatedPartyTransactionDomain455247422024-04-012024-09-30RelatedPartyTransactionDomain465247422024-03-31RelatedPartyTransactionDomain465247422024-09-30RelatedPartyTransactionDomain465247422024-04-012024-09-30RelatedPartyTransactionDomain475247422024-03-31RelatedPartyTransactionDomain475247422024-09-30RelatedPartyTransactionDomain475247422024-04-012024-09-30RelatedPartyTransactionDomain485247422024-03-31RelatedPartyTransactionDomain485247422024-09-30RelatedPartyTransactionDomain485247422024-04-012024-09-30RelatedPartyTransactionDomain495247422024-03-31RelatedPartyTransactionDomain495247422024-09-30RelatedPartyTransactionDomain495247422024-04-012024-09-30RelatedPartyTransactionDomain505247422024-03-31RelatedPartyTransactionDomain505247422024-09-30RelatedPartyTransactionDomain505247422024-04-012024-09-30RelatedPartyTransactionDomain515247422024-03-31RelatedPartyTransactionDomain515247422024-09-30RelatedPartyTransactionDomain515247422024-04-012024-09-30RelatedPartyTransactionDomain525247422024-03-31RelatedPartyTransactionDomain525247422024-09-30RelatedPartyTransactionDomain525247422024-04-012024-09-30RelatedPartyTransactionDomain535247422024-03-31RelatedPartyTransactionDomain535247422024-09-30RelatedPartyTransactionDomain535247422024-04-012024-09-30RelatedPartyTransactionDomain545247422024-03-31RelatedPartyTransactionDomain545247422024-09-30RelatedPartyTransactionDomain545247422024-04-012024-09-30RelatedPartyTransactionDomain555247422024-03-31RelatedPartyTransactionDomain555247422024-09-30RelatedPartyTransactionDomain555247422024-04-012024-09-30RelatedPartyTransactionDomain565247422024-03-31RelatedPartyTransactionDomain565247422024-09-30RelatedPartyTransactionDomain565247422024-04-012024-09-30RelatedPartyTransactionDomain575247422024-03-31RelatedPartyTransactionDomain575247422024-09-30RelatedPartyTransactionDomain575247422024-04-012024-09-30RelatedPartyTransactionDomain585247422024-03-31RelatedPartyTransactionDomain585247422024-09-30RelatedPartyTransactionDomain585247422024-04-012024-09-30RelatedPartyTransactionDomain595247422024-03-31RelatedPartyTransactionDomain595247422024-09-30RelatedPartyTransactionDomain595247422024-04-012024-09-30RelatedPartyTransactionDomain605247422024-03-31RelatedPartyTransactionDomain605247422024-09-30RelatedPartyTransactionDomain605247422024-04-012024-09-30RelatedPartyTransactionDomain615247422024-03-31RelatedPartyTransactionDomain615247422024-09-30RelatedPartyTransactionDomain615247422024-04-012024-09-30RelatedPartyTransactionDomain625247422024-03-31RelatedPartyTransactionDomain625247422024-09-30RelatedPartyTransactionDomain625247422024-04-012024-09-30RelatedPartyTransactionDomain635247422024-03-31RelatedPartyTransactionDomain635247422024-09-30RelatedPartyTransactionDomain635247422024-04-012024-09-30RelatedPartyTransactionDomain645247422024-03-31RelatedPartyTransactionDomain645247422024-09-30RelatedPartyTransactionDomain645247422024-04-012024-09-30RelatedPartyTransactionDomain655247422024-03-31RelatedPartyTransactionDomain655247422024-09-30RelatedPartyTransactionDomain655247422024-04-012024-09-30RelatedPartyTransactionDomain665247422024-03-31RelatedPartyTransactionDomain665247422024-09-30RelatedPartyTransactionDomain665247422024-04-012024-09-30RelatedPartyTransactionDomain675247422024-03-31RelatedPartyTransactionDomain675247422024-09-30RelatedPartyTransactionDomain675247422024-04-012024-09-30RelatedPartyTransactionDomain685247422024-03-31RelatedPartyTransactionDomain685247422024-09-30RelatedPartyTransactionDomain685247422024-04-012024-09-30RelatedPartyTransactionDomain695247422024-03-31RelatedPartyTransactionDomain695247422024-09-30RelatedPartyTransactionDomain695247422024-04-012024-09-30RelatedPartyTransactionDomain705247422024-03-31RelatedPartyTransactionDomain705247422024-09-30RelatedPartyTransactionDomain705247422024-04-012024-09-30RelatedPartyTransactionDomain715247422024-03-31RelatedPartyTransactionDomain715247422024-09-30RelatedPartyTransactionDomain715247422024-04-012024-09-30RelatedPartyTransactionDomain725247422024-03-31RelatedPartyTransactionDomain725247422024-09-30RelatedPartyTransactionDomain725247422024-04-012024-09-30RelatedPartyTransactionDomain735247422024-03-31RelatedPartyTransactionDomain735247422024-09-30RelatedPartyTransactionDomain735247422024-04-012024-09-30RelatedPartyTransactionDomain745247422024-03-31RelatedPartyTransactionDomain745247422024-09-30RelatedPartyTransactionDomain74iso4217:INRxbrli:pureCaplin Point Laboratories Limited524742CAPLIPOINTNOTLISTED2024-04-012025-03-31First half yearly2024-04-012024-09-30CrorestruetrueNANAfalsetrue2023-05-27https://www.caplinpoint.net/wp-content/uploads/2021/07/Related-Party-Transaction-Policy.pdfCaplin Point Laboratories LimitedDrogueria Saimed de Honduras S.AWholly owned step down SubsidiarySale of goods or services1500000000NA225600000184900000105500000Caplin Point Laboratories LimitedNuevos Eticos Neo Ethicals S.A - GuatemalaStep Down SubsidiarySale of goods or services2500000000NA1270800000135000000352200000Caplin Point Laboratories LimitedNeoethicals CIA.LTDA - EcuadorWholly owned step down SubsidiarySale of goods or services1500000000NA65600000-100000-70300000Caplin Point Laboratories LimitedNeo Ethicals S.A - NicaraguaWholly owned step down SubsidiarySale of goods or services1500000000NA628700000-48300000105700000Caplin Point Laboratories LimitedCaplin Point Laboratories Colombia SASWholly owned step down SubsidiarySale of goods or services0NA031000003100000Value of Related Party Transactions as approved by the Audit Committee - Not Applicable, as the counter party is a Wholly owned step-down Subsidiary of the listed entityCaplin Point Laboratories LimitedArgus Salud Pharma LLPSubsidiarySale of goods or services150000000NA451000002790000077400000Value of Related Party Transactions as approved by the Audit Committee - Aggregate value of INR 15 Crs for RPT.Since the format does not allow merging of cells, there is a repetition of INR 15 Crs.Caplin Point Laboratories LimitedAshvich Infotek Private LimitedDirectors and their relatives are interestedAny other transactionRent & Consultancy paid125000000NA47000009000001000000Caplin Point Laboratories LimitedCaplin Point Meenakshi CSR TrustTrust in which Promoter/ Promoter Group are Board of Trustees.Any other transactionCSR Contribution61600000NA5240000000INR 6.16 Crs is the current year CSR obligation. INR 5.24 Crs is the amount transferred to the CSR trust during the half year for carrying out the on-going project.Caplin Point Laboratories LimitedCaplin Steriles LimitedSubsidiaryAny other transactionAvailing of services & Rent for ETP4500000000NA30000000Based on the recommendation of the Audit Committee, the shareholders at the AGM held on 30-09-2024 had approved RPT between CPL and/ or subsidiaries with CSL with an aggregate limit of INR 450 Crs for each of the FY from 24-25 to 28-29. Since the format does not allow merging of cells, there is a repetition of INR 450 Crs.Caplin Point Laboratories LimitedCaplin Steriles LimitedSubsidiaryAny other transactionCommon expense recovery4500000000NA290000000Based on the recommendation of the Audit Committee, the shareholders at the AGM held on 30-09-2024 had approved RPT between CPL and/ or subsidiaries with CSL with an aggregate limit of INR 450 Crs for each of the FY from 24-25 to 28-29. Since the format does not allow merging of cells, there is a repetition of INR 450 Crs.Caplin Point Laboratories LimitedCaplin Steriles LimitedSubsidiaryAny other transactionRecovery of Software and Systems related Expense4500000000NA510000000Based on the recommendation of the Audit Committee, the shareholders at the AGM held on 30-09-2024 had approved RPT between CPL and/ or subsidiaries with CSL with an aggregate limit of INR 450 Crs for each of the FY from 24-25 to 28-29. Since the format does not allow merging of cells, there is a repetition of INR 450 Crs.Caplin Point Laboratories LimitedCaplin Steriles LimitedSubsidiarySale of goods or services4500000000NA4000000500000Based on the recommendation of the Audit Committee, the shareholders at the AGM held on 30-09-2024 had approved RPT between CPL and/ or subsidiaries with CSL with an aggregate limit of INR 450 Crs for each of the FY from 24-25 to 28-29. Since the format does not allow merging of cells, there is a repetition of INR 450 Crs.Caplin Point Laboratories LimitedCaplin Steriles LimitedSubsidiaryPurchase of goods or services4500000000NA830000000Based on the recommendation of the Audit Committee, the shareholders at the AGM held on 30-09-2024 had approved RPT between CPL and/ or subsidiaries with CSL with an aggregate limit of INR 450 Crs for each of the FY from 24-25 to 28-29. Since the format does not allow merging of cells, there is a repetition of INR 450 Crs.Caplin Point Laboratories LimitedCaplin Steriles LimitedSubsidiaryAny other transactionSale of RODTEP Scip license4500000000NA880000000Based on the recommendation of the Audit Committee, the shareholders at the AGM held on 30-09-2024 had approved RPT between CPL and/ or subsidiaries with CSL with an aggregate limit of INR 450 Crs for each of the FY from 24-25 to 28-29. Since the format does not allow merging of cells, there is a repetition of INR 450 Crs.Caplin Point Laboratories LimitedCaplin Steriles LimitedSubsidiaryLoan4250000000NA14500000026200000002415000000Loan0.107510 years (5 yrs moratorium + 5 years repayment)UnsecuredCapex ProjectValue of Related Party Transactions as approved by the Audit Committee is INR 425 Crs in aggregate. Since the format does not allow merging of cells, there is a repetition of INR 425 Crs. Further, during year there was both loan given and repaid. Since the format does not allow merging of cells, there is a repetition of opening and closing balanceCaplin Point Laboratories LimitedCaplin Steriles LimitedSubsidiaryInterest received0NA13170000000Value of RPT as approved by the Audit Committee - State Bank of India’s Marginal Cost of Fund based Lending Rate (MCLR) + 2% SpreadCaplin Point Laboratories LimitedCaplin One Labs Limited (Formerly Known as Caplin Onco Limited)Wholly owned SubsidiarySale of goods or services0NA2000000100000Value of Related Party Transactions as approved by the Audit Committee - Not Applicable, as the counter party is a Wholly Subsidiary of the listed entityCaplin Point Laboratories LimitedCaplin One Labs Limited (Formerly Known as Caplin Onco Limited)Wholly owned SubsidiaryAny other transactionRent received0NA320000000Value of Related Party Transactions as approved by the Audit Committee - Not Applicable, as the counter party is a Wholly owned Subsidiary of the listed entityCaplin Point Laboratories LimitedCaplin One Labs Limited (Formerly Known as Caplin Onco Limited)Wholly owned SubsidiaryLoan0NA100000060000000Loan0.10753 monthsUnsecuredWorking CapitalValue of Related Party Transactions as approved by the Audit Committee - Not Applicable, as the counter party is a Wholly owned Subsidiary of the listed entity. During year there was both loan given and repaid. Since the format does not allow merging of cells, there is a repetition of opening and closing balance.Caplin Point Laboratories LimitedCaplin One Labs Limited (Formerly Known as Caplin Onco Limited)Wholly owned SubsidiaryInterest received0NA000Value of Related Party Transactions as approved by the Audit Committee - Not Applicable, as the counter party is a Wholly owned Subsidiary of the listed entity. Valuation of the transaction is INR 0.003Caplin Point Laboratories LimitedDr. Sridhar GanesanKey Management PersonnelRemuneration0NA280000000Value of Related Party Transactions as approved by the Audit Committee - Not Applicable.Caplin Point Laboratories LimitedMr. Muralidharan DKey Management PersonnelRemuneration0NA250000000Value of Related Party Transactions as approved by the Audit Committee - Not Applicable.Caplin Point Laboratories LimitedMr. Partheeban Vivek SiddarthChief Operating OfficerRemuneration0NA90000000Value of Related Party Transactions as approved by the Audit Committee - Not Applicable.Caplin Point Laboratories LimitedMr. Venkatram GKey Management PersonnelRemuneration0NA190000000Value of Related Party Transactions as approved by the Audit Committee - Not Applicable.Caplin Point Laboratories LimitedMr. Venkatram GKey Management PersonnelAny other transactionEquity Shares Pursuant to employees stock option scheme0NA130000000Value of Related Party Transactions as approved by the Audit Committee - Not Applicable.Caplin Point Laboratories LimitedMr. D SathyanarayananIndependent DirectorAny other transactionSitting Fees0NA20000000Value of Related Party Transactions as approved by the Audit Committee - Not Applicable.Caplin Point Laboratories LimitedDr. C K GariyaliIndependent DirectorAny other transactionSitting Fees0NA20000000Value of Related Party Transactions as approved by the Audit Committee - Not Applicable.Caplin Point Laboratories LimitedMr. S DeenadayalanIndependent DirectorAny other transactionSitting Fees0NA30000000Value of Related Party Transactions as approved by the Audit Committee - Not Applicable.Caplin Point Laboratories LimitedDr R NagendranIndependent DirectorAny other transactionSitting Fees0NA20000000Value of Related Party Transactions as approved by the Audit Committee - Not Applicable.Caplin Point Laboratories LimitedArgus Salud Pharma LLPSubsidiaryAny other transactionShare of profit from the LLP150000000NA5900000440000010300000Value of Related Party Transactions as approved by the Audit Committee - Aggregate value of INR 15 Crs for RPT.Since the format does not allow merging of cells, there is a repetition of INR 15 Crs.Caplin Point Laboratories LimitedDr.Gunasakaran SambandanRelated Party of the subsidiaryRemuneration0NA120000000Value of Related Party Transactions as approved by the Audit Committee - Not Applicable.Caplin Point Laboratories LimitedDr.Gunasakaran SambandanRelated Party of the subsidiaryAny other transactionEquity Shares Pursuant to employees stock option scheme0NA110000000Value of Related Party Transactions as approved by the Audit Committee - Not Applicable.Caplin Point Laboratories LimitedMs.Nisha RajendranRelated Party of the subsidiaryRemuneration0NA110000000Value of Related Party Transactions as approved by the Audit Committee - Not Applicable.Caplin Point Laboratories LimitedMs.Nisha RajendranRelated Party of the subsidiaryAny other transactionEquity Shares Pursuant to employees stock option scheme0NA110000000Value of Related Party Transactions as approved by the Audit Committee - Not Applicable.Caplin Point Laboratories LimitedAshvich Property Private LimitedDirectors and their relatives are interestedAny other transactionRent paid20000000NA17000003000000Value of Related Party Transactions as approved by the Audit Committee - Not Applicable.Caplin Steriles LimitedCaplin One Labs Limited (Formerly Known as Caplin Onco Limited)Fellow subsidiarySale of goods or services351300000NA35130000000Caplin Steriles LimitedCaplin One Labs Limited (Formerly Known as Caplin Onco Limited)Fellow subsidiaryAny other transactionRent paid0NA160000000Value of Related Party Transactions as approved by the Audit Committee - Not Applicable, as the transactions did not cross the threshold limit for approval.Caplin Steriles LimitedAshvich Infotek Private LimitedDirectors and their relatives are interestedAny other transactionRent & Consultancy paid0NA66000002500000800000Value of Related Party Transactions as approved by the Audit Committee - Not Applicable, as the transactions did not cross the threshold limit for approval.Caplin Steriles LimitedSunsole Solar Private LimitedAssociate CompanyPurchase of goods or services0NA1170000000Value of Related Party Transactions as approved by the Audit Committee - Not Applicable, as the transactions did not cross the threshold limit for approval.Caplin Steriles LimitedCaplin Steriles USA Inc.Wholly owned Subsidiary CompanyAny other transactionEquity Investment4500000000NA13410000025000000159100000Based on the recommendation the Audit Committee, the shareholders at the AGM held on 30-09-2024 had approved RPT between CPL and/ or subsidiaries with CSL with an aggregate limit of INR 450 Crs for each of the FY from 24-25 to 28-29. Since the format does not allow merging of cells, there is a repetition INR 450 Crs.Caplin Steriles LimitedNuevos Eticos Neo Ethicals S.A - GuatemalaFellow subsidiarySale of goods or services4500000000NA88000000900000Based on the recommendation the Audit Committee, the shareholders at the AGM held on 30-09-2024 had approved RPT between CPL and/ or subsidiaries with CSL with an aggregate limit of INR 450 Crs for each of the FY from 24-25 to 28-29. Since the format does not allow merging of cells, there is a repetition INR 450 Crs.Caplin Steriles LimitedMr. M Sathya NarayananKey Management PersonnelRemuneration0NA370000000Value of Related Party Transactions as approved by the Audit Committee - Not Applicable.Caplin Steriles LimitedMr. M Sathya NarayananKey Management PersonnelAny other transactionEquity Shares Pursuant to employees stock option scheme0NA500000000Value of Related Party Transactions as approved by the Audit Committee - Not Applicable. The Company's ESOP scheme is extended to the employees of the subsidiaries. Thus, the shares of CPL, pursuant to ESOP has been allotted.Caplin Steriles LimitedDr K C JohnIndependent DirectorAny other transactionSitting Fees0NA20000000Value of Related Party Transactions as approved by the Audit Committee - Not Applicable.Caplin Steriles LimitedMr R ViswanathanIndependent DirectorAny other transactionSitting Fees0NA10000000Value of Related Party Transactions as approved by the Audit Committee - Not Applicable.Caplin Steriles LimitedMs. S. RukmaniKey Management PersonnelRemuneration0NA70000000Value of Related Party Transactions as approved by the Audit Committee - Not Applicable.Caplin One Labs Limited (Formerly Known as Caplin Onco Limited)Ashvich Infotek Private LimitedFellow subsidiaryAny other transactionRent paid0NA10000000Value of Related Party Transactions as approved by the Audit Committee - Not Applicable, as the transactions did not cross the threshold limit for approval. Closing balance is INR 0.001Caplin One Labs Limited (Formerly Known as Caplin Onco Limited)Nuevos Eticos Neo Ethicals S.A - GuatemalaFellow subsidiarySale of goods or services0NA019000000Value of Related Party Transactions as approved by the Audit Committee - Not Applicable, as the transactions did not cross the threshold limit for approval.Caplin One Labs Limited (Formerly Known as Caplin Onco Limited)Neo Ethicals S.A - NicaraguaFellow subsidiarySale of goods or services0NA18000000-56600000Value of Related Party Transactions as approved by the Audit Committee - Not Applicable, as the transactions did not cross the threshold limit for approval.Argus Salud Pharma LLPDrogueria Saimed de Honduras S.AFellow subsidiarySale of goods or services0NA620000031000009400000Value of Related Party Transactions as approved by the Audit Committee - Not Applicable, as the transactions did not cross the threshold limit for approval.Argus Salud Pharma LLPMay India Property Private LimitedPatners/directors are interestedAny other transactionShare of profit from the LLP0NA000Value of Related Party Transactions as approved by the Audit Committee - Not Applicable, as the transactions did not cross the threshold limit for approval. Opening & Closing balance is INR 0.0005062Caplin Point Far East Limited, (Hong Kong)Caplin One Labs Limited (Formerly Known as Caplin Onco Limited)Fellow subsidiaryLoan0NA7583000008337000001592000000Loan0.063310 years (3 yrs moratorium + 7 years repayment)UnsecuredCapexValue of Related Party Transactions as approved by the Audit Committee - Not Applicable, as both the parties are WoSCaplin Point Far East Limited, (Hong Kong)Caplin Point Laboratories Colombia SASWholly owned Subsidiary CompanyAny other transactionInvestment50000000NA03710000037100000Value of Related Party Transactions as approved by the Audit Committee - Aggregate limit of RPT is INR 5 Crs. Since the format does not allow merging of cells, there is a repetition. Caplin Point Far East Limited, (Hong Kong)Caplin Point Laboratories Colombia SASWholly owned Subsidiary CompanyAny other transactionExpenses Reimbursement50000000NA020000000Value of Related Party Transactions as approved by the Audit Committee - Aggregate limit of RPT is INR 5 Crs. Since the format does not allow merging of cells, there is a repetition. Caplin Point Far East Limited, (Hong Kong)Drogueria Saimed de Honduras S.AWholly owned Subsidiary CompanySale of goods or services750000000NA11400000651000000664300000Caplin Point Far East Limited, (Hong Kong)Nuevos Eticos Neo Ethicals S.A - GuatemalaSubsidiarySale of goods or services1000000000NA3784000001121200000759000000Caplin Point Far East Limited, (Hong Kong)Neoethicals CIA.LTDA - EcuadorWholly owned Subsidiary CompanySale of goods or services500000000NA61800000689500000538900000Caplin Point Far East Limited, (Hong Kong)Neo Ethicals S.A - NicaraguaWholly owned Subsidiary CompanySale of goods or services600000000NA1976000009200000076900000Caplin Point Far East Limited, (Hong Kong)Caplin Point El Salvador, S.A. De C.V.Wholly owned Subsidiary CompanySale of goods or services200000000NA0-98900000-82800000Caplin Steriles USA IncDr.Gunasakaran SambandanDirectorRemuneration0NA170000000Value of Related Party Transactions as approved by the Audit Committee - Not Applicable.Drogueria Saimed De HondurasNeo Ethicals S.A - NicaraguaFellow subsidiaryPurchase of goods or services0NA02660000026600000Value of Related Party Transactions as approved by the Audit Committee - Not Applicable, as both the parties are WoSNeo Ethicals SA NicaraguaCaplin Point El Salvador, S.A. De C.V.Fellow subsidiaryPurchase of goods or services0NA017000001700000Value of Related Party Transactions as approved by the Audit Committee - Not Applicable, as both the parties are WoSNeo Ethicals SA NicaraguaNeoethicals CIA.LTDA - EcuadorFellow subsidiaryPurchase of goods or services0NA01440000014400000Value of Related Party Transactions as approved by the Audit Committee - Not Applicable, as both the parties are WoSNeoethicals CIA.LTDA - EcuadorDrogueria Saimed de Honduras S.AFellow subsidiarySale of goods or services0NA014000000Value of Related Party Transactions as approved by the Audit Committee - Not Applicable, as both the parties are WoSNuevos Eticos Neoethicals S.A GuatemalaDrogueria Saimed de Honduras S.AFellow subsidiarySale of goods or services0NA29000003810000018500000Value of Related Party Transactions as approved by the Audit Committee - Not Applicable, as both the parties are Foreign entitiesNuevos Eticos Neoethicals S.A GuatemalaNeo Ethicals S.A - NicaraguaFellow subsidiarySale of goods or services0NA136000006500000078700000Value of Related Party Transactions as approved by the Audit Committee - Not Applicable, as both the parties are Foreign entitiesNuevos Eticos Neoethicals S.A GuatemalaNeoethicals CIA.LTDA - EcuadorFellow subsidiarySale of goods or services0NA38000002430000028200000Value of Related Party Transactions as approved by the Audit Committee - Not Applicable, as both the parties are Foreign entitiesNuevos Eticos Neoethicals S.A GuatemalaDrogueria Saimed de Honduras S.AFellow subsidiaryPurchase of goods or services0NA093000009400000Value of Related Party Transactions as approved by the Audit Committee - Not Applicable, as both the parties are Foreign entitiesNuevos Eticos Neoethicals S.A GuatemalaNeoethicals CIA.LTDA - EcuadorFellow subsidiaryPurchase of goods or services0NA02290000023200000Value of Related Party Transactions as approved by the Audit Committee - Not Applicable, as both the parties are Foreign entitiesCaplin Steriles LimitedDr. C K GariyaliIndependent DirectorAny other transactionSitting Fees0NA20000000Value of Related Party Transactions as approved by the Audit Committee - Not Applicable.Nuevos Eticos Neoethicals S.A GuatemalaNeo Ethicals S.A - NicaraguaFellow subsidiaryPurchase of goods or services0NA0149000000Value of Related Party Transactions as approved by the Audit Committee - Not Applicable, as both the parties are Foreign entitiesNuevos Eticos Neoethicals S.A GuatemalaMr. Ashok Gorkey PartheebanBusiness Head LatamRemuneration0NA1250000000Value of Related Party Transactions as approved by the Audit Committee - Not Applicable.Caplin Point Laboratories LimitedCaplin One Labs Limited (Formerly Known as Caplin Onco Limited)Wholly owned SubsidiaryAny other transactionLoan Repayment Received0NA700000060000000Value of Related Party Transactions as approved by the Audit Committee - Not Applicable, as the counter party is a Wholly owned Subsidiary of the listed entity. During year there was both loan given and repaid. Since the format does not allow merging of cells, there is a repetition of opening and closing balance.Caplin Point Laboratories LimitedCaplin Steriles LimitedSubsidiaryAny other transactionLoan Repayment Received4250000000035000000026200000002415000000Value of Related Party Transactions as approved by the Audit Committee is INR 425 Crs in aggregate. Since the format does not allow merging of cells, there is a repetition of INR 425 Crs. Further, during year there was both loan given and repaid. Since the format does not allow merging of cells, there is a repetition of opening and closing balance4953300000